Welcome to our dedicated page for Bruker SEC filings (Ticker: BRKR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Bruker Corporation (Nasdaq: BRKR) SEC filings page provides access to the company’s U.S. regulatory disclosures, including current reports on Form 8-K, annual reports on Form 10-K, quarterly reports on Form 10-Q, and other key documents. These filings offer detailed information on Bruker’s financial condition, operating performance, capital structure, and material corporate events.
Bruker’s Form 8-K filings illustrate how the company reports significant developments such as quarterly and interim financial results, material modifications to security holder rights, and securities offerings. For example, Bruker has filed 8-Ks to furnish press releases with results of operations and financial condition for specific quarters, and to describe the issuance and terms of its 6.375% Mandatory Convertible Preferred Stock, Series A. That filing outlines the preferred stock’s dividend rate, liquidation preference, conversion mechanics into common stock, and related restrictions on dividends and share repurchases affecting junior and parity stock.
Through Forms 10-K and 10-Q, users can review segment information for Bruker Scientific Instruments and the Bruker Energy & Supercon Technologies (BEST) division, along with discussions of markets served, risk factors, and management’s analysis of results. These filings also describe how Bruker’s scientific instruments and diagnostic solutions support life science, applied, biopharma, industrial and cleantech research, and semiconductor metrology applications.
On this page, Stock Titan enhances Bruker’s raw SEC filings with AI-powered summaries that explain complex sections in plain language. Users can quickly understand the implications of Bruker’s 10-K and 10-Q reports, preferred stock terms, and other material events, while still having direct access to the original EDGAR documents. Filings related to insider transactions on Form 4 and proxy materials on Schedule 14A can also be monitored to track executive equity activity and governance matters over time.
Mark Munch, Executive Vice President and President of Bruker Nano Inc., reported three non-derivative transactions in Bruker Corporation (BRKR) common stock related to restricted stock unit vesting. The Form 4 shows shares were withheld to satisfy tax withholding obligations: 1,340 shares on 08/09/2025 at $30.43, 1,107 shares on 08/10/2025 at $30.43, and 1,279 shares on 08/11/2025 at $30.78. Each transaction is reported as a direct ownership change and coded as F with the company’s explanation confirming tax withholding for RSU vesting.
Following these withholdings, the reported direct beneficial ownership amounts after each transaction were 107,198, 106,091 and 104,812 shares respectively, reflecting a total of 3,726 shares withheld across the three dates.
Frank H. Laukien, President & CEO, Director and 10% owner of Bruker Corporation (BRKR), had restricted stock units vest and had 12,917 shares withheld across three dates to satisfy tax withholding: 3,422 shares on 08/09/2025 at $30.43, 4,657 shares on 08/10/2025 at $30.43, and 4,838 shares on 08/11/2025 at $30.78. The transactions are coded F, indicating company withholding rather than open-market sales.
Following the withholdings, his reported direct beneficial ownership was about 38.45 million shares (38,445,672 after the 08/11 transaction). The filing also lists indirect holdings including 1,055,639 shares by a former spouse and various family/UTMA holdings, showing structured family ownership but no additional dispositions reported.
Herman Gerald N., Executive Vice President and CFO of Bruker Corporation, reported the withholding of vested restricted stock units to satisfy tax obligations. The Form 4 shows three withholding transactions over August 9–11, 2025: 1,846 shares on 08/09 at $30.43, 1,380 shares on 08/10 at $30.43, and 1,420 shares on 08/11 at $30.78. The company’s explanatory note states these shares were withheld to cover taxes arising from vesting of previously granted RSUs.
Following the reported transactions, the filing lists beneficial ownership declining across those dates to 79,539, then 78,159, and finally 76,739 shares held directly by the reporting person. These entries are recorded under Transaction Code F and are presented as direct ownership on the Form 4.